Actinogen Medical Ltd (acw) Logo

Actinogen Medical Ltd (ACW)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

ACW ASX Chart

Snapshot

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is an association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2025 YTD
1 Year
vs Sector (1yr) -35.37%
vs ASX 200 (1yr) -50.10%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,116 of 2,323
Sector Rank 88 of 231

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies BXN / PEB / PIQ
EPS -$0.003
DPS $0.00
Book Value Per Share $0.008

Broker Consensus

ACW is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website www.actinogen.com.au
Registry Automic Group
Auditor Ernst & Young
Date Listed 16 Oct 2007

Upcoming Calendar (Forecasted)

Date Event
29/08/2025 Report (Prelim)
29/08/2025 Report (Annual)
10/10/2025 Report (Annual)
23/02/2026 Report (Interim)

Former Company Names

  • Actinogen Limited (ACW), 17/11/2015

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ACW directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
24/03/25 Nicki Vasquez Issued 2,000,000 $0.043 $85,000 Issued under employee share plan
24/03/25 Malcolm McComas Issued 2,000,000 $0.043 $85,000 Issued under employee share plan
24/03/25 George Morstyn Issued 2,000,000 $0.043 $85,000 Issued under employee share plan
24/03/25 Steven Gourlay Issued 21,000,000 $0.042 $882,000 Issued under employee share plan
24/03/25 Geoffrey Brooke Expiry 5,000,000 $0.034 $170,000 Options expired
24/03/25 Geoffrey Brooke Issued 8,000,000 $0.043 $340,000 Issued under employee share plan
04/11/24 Malcolm McComas Issued 1,000,000 $0.03 $30,000 Placement
04/11/24 Malcolm McComas Issued 750,000 $0.025 $18,750 Placement
04/11/24 George Morstyn Issued 1,666,668 $0.03 $50,000 Placement
04/11/24 George Morstyn Issued 1,250,001 $0.025 $31,250 Placement
04/11/24 Steven Gourlay Issued 33,333,334 $0.03 $1,000,000 Placement
04/11/24 Steven Gourlay Issued 25,000,000 $0.025 $625,000 Placement
04/11/24 Geoffrey Brooke Issued 1,666,668 $0.03 $50,000 Placement
04/11/24 Geoffrey Brooke Issued 1,250,001 $0.025 $31,250 Placement
05/06/24 Malcolm McComas Issued 148,241 $0.025 $3,706 Rights issue
05/06/24 Malcolm McComas Issued 300,000 $0.025 $7,500 Rights issue
05/06/24 George Morstyn Issued 521,456 $0.025 $13,036 Rights issue
05/06/24 George Morstyn Issued 226,969 $0.025 $5,674 Rights issue
05/06/24 Malcolm McComas Issued 224,121 $0.029 $6,499 Rights issue
05/06/24 George Morstyn Issued 374,213 $0.029 $10,852 Rights issue
05/06/24 Steven Gourlay Issued 1,285,120 $0.025 $32,128 Rights issue
05/06/24 Steven Gourlay Issued 3,514,880 $0.025 $87,872 Rights issue
05/06/24 Steven Gourlay Issued 2,400,000 $0.029 $69,600 Rights issue
05/06/24 Geoffrey Brooke Issued 175,085 $0.025 $4,377 Rights issue
05/06/24 Geoffrey Brooke Issued 1,003,378 $0.025 $25,084 Rights issue
05/06/24 Geoffrey Brooke Issued 589,232 $0.029 $17,087 Rights issue
05/06/24 Nicki Vasquez Issued 366,667 $0.025 $9,166 Rights issue
05/06/24 Nicki Vasquez Issued 183,334 $0.029 $5,316 Rights issue
04/04/24 Malcolm McComas Expiry 3,000,000 $0.029 $87,000 Options expired
01/12/23 Nicki Vasquez Issued 5,500,000 $0.031 $171,875 Issued under employee share plan
01/12/23 Malcolm McComas Issued 4,500,000 $0.031 $140,625 Issued under employee share plan
01/12/23 George Morstyn Issued 4,500,000 $0.031 $140,625 Issued under employee share plan
01/12/23 Steven Gourlay Issued 20,000,000 $0.031 $625,000 Issued under employee share plan
01/12/23 Geoffrey Brooke Issued 12,000,000 $0.031 $375,000 Issued under employee share plan
27/11/23 George Morstyn Expiry 1,500,000 $0.023 $34,500 Options expired
27/11/23 Geoffrey Brooke Expiry 4,900,000 $0.023 $112,700 Options expired
11/09/23 Malcolm McComas Issued 401,372 $0.025 $10,034 Rights issue
11/09/23 Malcolm McComas Issued 200,687 $0.022 $4,415 Rights issue
11/09/23 George Morstyn Issued 614,537 $0.025 $15,363 Rights issue
11/09/23 George Morstyn Issued 599,610 $0.025 $14,990 Rights issue
11/09/23 George Morstyn Issued 607,074 $0.022 $13,355 Rights issue
11/09/23 Steven Gourlay Issued 1,405,727 $0.025 $35,143 Rights issue
11/09/23 Steven Gourlay Issued 3,479,565 $0.025 $86,989 Rights issue
11/09/23 Steven Gourlay Issued 2,442,647 $0.022 $53,738 Rights issue
11/09/23 Geoffrey Brooke Issued 550,661 $0.025 $13,766 Rights issue
11/09/23 Geoffrey Brooke Issued 474,058 $0.025 $11,851 Rights issue
11/09/23 Geoffrey Brooke Issued 512,360 $0.022 $11,271 Rights issue
11/11/22 George Morstyn Buy +1,500,000 $0.10 $150,000 Exercise of options
11/11/22 George Morstyn Exercise 1,500,000 $0.10 $150,000 Exercise of options
03/11/22 Steven Gourlay Buy +750,000 $0.125 $93,507 On-market trade
20/05/22 Geoffrey Brooke Buy +340,000 $0.075 $25,362 On-market trade
12/05/22 Steven Gourlay Buy +2,000,000 $0.064 $128,240 On-market trade
06/04/22 Steven Gourlay Issued 797,222 $0.135 $107,624 Placement
20/12/21 Malcolm McComas Issued 222,223 $0.135 $30,000 Participation in share purchase plan
20/12/21 George Morstyn Issued 222,223 $0.135 $30,000 Participation in share purchase plan
20/12/21 Geoffrey Brooke Issued 222,223 $0.135 $30,000 Participation in share purchase plan
18/11/21 Geoffrey Brooke Issued 2,500,000 $0.20 $500,000 Issued under employee share plan
18/11/21 George Morstyn Issued 1,000,000 $0.20 $200,000 Issued under employee share plan
18/11/21 Malcolm McComas Issued 1,000,000 $0.20 $200,000 Issued under employee share plan
17/11/20 Malcolm McComas Issued 100,000 $0.022 $2,200 Rights issue
17/11/20 George Morstyn Issued 40,000 $0.022 $880 Rights issue
17/11/20 John (Bill) Ketelbey Issued 1,862,182 $0.022 $40,968 Rights issue
17/11/20 John (Bill) Ketelbey Issued 128,579 $0.022 $2,828 Rights issue
17/11/20 Geoffrey Brooke Issued 265,000 $0.022 $5,830 Rights issue
31/01/20 John (Bill) Ketelbey Cancelled 3,000,000 $0.035 $105,000 Cancellation of securities
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.05 $450,000 As advised by the company
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.05 $450,000 As advised by the company
12/04/19 Malcolm McComas Issued 3,000,000 $0.052 $156,000 Issue of options
13/12/18 Geoffrey Brooke Issued 4,900,000 $0.048 $235,200 Issue of options
13/12/18 John (Bill) Ketelbey Issued 11,700,000 $0.048 $561,600 Issue of options
13/07/18 Geoffrey Brooke Issued 300,000 $0.05 $15,000 Participation in share purchase plan
13/07/18 John (Bill) Ketelbey Issued 300,000 $0.05 $15,000 Participation in share purchase plan
01/06/18 George Morstyn Buy +200,000 $0.051 $10,282 On-market trade
22/01/18 Geoffrey Brooke Issued 625,000 $0.04 $25,000 Placement
21/12/17 Geoffrey Brooke Issued 53,333 $0.044 $2,347 Issue of options
21/12/17 Jason Loveridge Issued 3,716,677 $0.044 $163,534 Issue of options
21/12/17 John (Bill) Ketelbey Issued 1,647,172 $0.044 $72,476 Issue of options
29/03/17 Geoffrey Brooke Buy +400,000 $0.066 $26,521 On-market trade
24/12/15 John (Bill) Ketelbey Buy +10,909 $0.058 $630 On-market trade
Show All

Director Interests

The current holdings of ACW directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Nicki Vasquez 24/03/2025 7,500,000 N/A 183,334 N/A
Steven Gourlay 24/03/2025 130,366,241 20,561,907 29,842,647 N/A
Geoffrey Brooke 24/03/2025 18,855,405 24,054,039 2,351,593 N/A
Malcolm McComas 24/03/2025 4,800,000 6,800,000 1,174,808 N/A
George Morstyn 24/03/2025 10,343,289 5,300,174 2,231,288 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 5, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 249,527,468 9.19%
Dr Steven Gourlay 72,677,180 2.68%
Citicorp Nominees Pty Limited 55,901,720 2.06%
JSC Wealth Management Pty Ltd 52,966,360 1.95%
Old College Capital Holdings Limited 48,147,864 1.78%
Mrs Sarah Cameron 35,600,000 1.31%
Precision Opportunities Fund Pty Ltd <Investment A/C> 35,000,000 1.29%
Garnsworthy Pension Fund Pty Ltd <Garnsworthy Pension Fund A/C> 31,500,000 1.16%
Tisia Nominees Pty Ltd <Henderson Family A/C> 31,403,330 1.16%
Rickenbacker Capital Investments Pty Ltd 28,100,000 1.04%
Kaleidoscope Holdings Pty Ltd <Kaleidoscope Super A/C> 26,483,275 0.98%
Structure Investments Pty Ltd <Rogers Family A/C> 24,347,335 0.90%
Mr James Murch & Mrs Catherine Murch <MINJAL Super Fund A/C> 23,971,378 0.88%
Alua Nominees Pty Ltd 22,688,291 0.84%
Mr Guillermo Cesar Orselli & Dr David Matthew Krelle 21,963,421 0.81%
SVE Capital Pty Ltd <Strategic Vision Unit A/C> 21,146,116 0.78%
SG Gourlay Nominees Pty Ltd <SF Gourlay Family A/C> 20,561,907 0.76%
Peter Kyros Pty Ltd <Kyros SF A/C> 19,530,676 0.72%
Iral Pty Ltd <IRAL A/C> 19,524,230 0.72%
Mrs Gillian Karen Nes & Mrs Ronald Nes <GIRO S/F A/C> 19,500,000 0.72%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 127 254 593 2,391 1,822 5,187

Substantial Shareholders

No Substantial Shareholders for ACW in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
19-05-25 BVF Partners L.P 198,244,103 6.24 --
17-04-25 BVF Partners L.P 30,090,577 7.29 6.24
16-12-24 BVF Partners L.P 19,000,000 8.40 7.29

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.062 28 June
2023 $0.04 30 June
2022 $0.05 30 June
2021 $0.13 30 June
2020 $0.022 30 June
2019 $0.01 28 June
2018 $0.048 29 June
2017 $0.061 30 June
2016 $0.072 30 June
2015 $0.072 30 June
2014 $0.011 30 June
ACW Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.